17 results for author:"Iglehart J.D." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| The p110alpha and p110beta isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis. Utermark T., Rao T., Cheng H., Wang Q., Lee S.H., Wang Z.C., Iglehart J.D., Roberts T.M., Muller W.J., Zhao J.J. Genes Dev. 26:1573-1586(2012) · Mapped (8) |
| DNA ends alter the molecular composition and localization of Ku multicomponent complexes. Adelmant G., Calkins A.S., Garg B.K., Card J.D., Askenazi M., Miron A., Sobhian B., Zhang Y., Nakatani Y., Silver P.A. et al. Mol. Cell Proteomics 11:411-421(2012) · Mapped (10) |
| Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. Li Y., Zhang Q., Tian R., Wang Q., Zhao J.J., Iglehart J.D., Wang Z.C., Richardson A.L. Cancer Res. 71:7481-7489(2011) · Mapped (2) |
| Therapeutic implications of GIPC1 silencing in cancer. Chittenden T.W., Pak J., Rubio R., Cheng H., Holton K., Prendergast N., Glinskii V., Cai Y., Culhane A., Bentink S. et al. PLoS ONE 5:e15581-e15581(2010) · Mapped (2) |
| PIK3CA mutations in in situ and invasive breast carcinomas. Miron A., Varadi M., Carrasco D., Li H., Luongo L., Kim H.J., Park S.Y., Cho E.Y., Lewis G., Kehoe S. et al. Cancer Res. 70:5674-5678(2010) · Mapped (7) |
| Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. Qiao M., Wang Y., Xu X., Lu J., Dong Y., Tao W., Stein J., Stein G.S., Iglehart J.D., Shi Q. et al. Mol. Cell 38:512-523(2010) · Mapped (15) |
| SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis. Cheng H., Liu P., Wang Z.C., Zou L., Santiago S., Garbitt V., Gjoerup O.V., Iglehart J.D., Miron A., Richardson A.L. et al. Sci. Signal. 2:RA35-RA35(2009) · UniProtKB (2) · Mapped (41) |
| Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells. You F., Roberts L.A., Kang S.P., Nunes R.A., Dias C., Iglehart J.D., Solomon N.A., Friedman P.N., Harris L.N. J Hematol Oncol 1:2-2(2008) · Mapped (9) |
| Circulating colony stimulating factor-1 and breast cancer risk. Tamimi R.M., Brugge J.S., Freedman M.L., Miron A., Iglehart J.D., Colditz G.A., Hankinson S.E. Cancer Res. 68:18-21(2008) · Mapped (3) |
| Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Singh S., Shi Q., Bailey S.T., Palczewski M.J., Pardee A.B., Iglehart J.D., Biswas D.K. Mol. Cancer Ther. 6:1973-1982(2007) · Mapped (1) |
| Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery. Shi Q., Harris L.N., Lu X., Li X., Hwang J., Gentleman R., Iglehart J.D., Miron A. J. Proteome Res. 5:2947-2955(2006) · Mapped (8) |
| The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy. Golshan M., Miron A., Nixon A.J., Garber J.E., Cash E.P., Iglehart J.D., Harris J.R., Wong J.S. Am. J. Surg. 192:58-62(2006) · Mapped (21) |
| Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses. Bluman L.G., Rimer B.K., Regan Sterba K., Lancaster J., Clark S., Borstelmann N., Iglehart J.D., Winer E.P. Psychooncology 12:410-427(2003) · Mapped (18) |
| M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Hankins G.R., De Souza A.T., Bentley R.C., Patel M.R., Marks J.R., Iglehart J.D., Jirtle R.L. Oncogene 12:2003-2009(1996) · Mapped (2) |
| BRCA2 mutations in primary breast and ovarian cancers. Lancaster J.M., Wooster R., Mangion J., Phelan C.M., Cochran C., Gumbs C., Seal S., Barfoot R., Collins N., Bignell G. et al. Nat. Genet. 13:238-240(1996) · UniProtKB (1) |
| BRCA1 mutations in primary breast and ovarian carcinomas. Futreal P.A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K., Tavtigian S., Bennett L.M., Haugen-Strano A., Swensen J., Miki Y. et al. Science 266:120-122(1994) · UniProtKB (1) |
| Overexpression and mutation of p53 in endometrial carcinoma. Kohler M.F., Berchuck A., Davidoff A.M., Humphrey P.A., Dodge R.K., Iglehart J.D., Soper J.T., Clarke-Pearson D.L., Bast R.C. Jr., Marks J.R. Cancer Res. 52:1622-1627(1992) · Mapped (2) |